Erin Borns, PA
Physician Assistant · Omaha, NENPI 1639562630
Payments from drug & device makers
Across 116 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$397
- AbbVie$374
- Novo Nordisk$295
- Pfizer$155
- Adaptive Biotechnologies Corporation$140
- Boehringer Ingelheim$125
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,43896%
- Education$954%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 11 | $397 |
| AbbVie | 20 | $374 |
| Novo Nordisk | 18 | $295 |
| Pfizer | 9 | $155 |
| Adaptive Biotechnologies Corporation | 3 | $140 |
| Boehringer Ingelheim | 1 | $125 |
| AVEO Pharmaceuticals, Inc. | 2 | $95 |
| Karyopharm Therapeutics Inc. | 2 | $88 |
| Bayer | 5 | $80 |
| Lilly USA, LLC | 4 | $54 |
| Genentech USA, Inc. | 3 | $53 |
| Eisai Inc. | 3 | $51 |
| Novartis | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Abbott | 2 | $33 |
| Trisalus Life Sciences, Inc. | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Merck | 2 | $26 |
| GSK | 2 | $25 |
| Genmab U.S., Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $23 |
| Syndax Pharmaceuticals, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Octapharma USA, Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Coherus Oncology, Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Pharmaand GmbH | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,533 in reported general payments places this provider in the 85th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 11 | $140 |
| Levothyroxine Sodium | 11 | $131 |
| Simvastatin | 12 | $101 |
| Potassium Chloride | 12 | $67 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Omaha
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Christopher BeasleyOmaha$15K
- Corrine GiggeeOmaha$12K
- Austin DuerksenOmaha$12K
- Erin HoffmanOmaha$12K
- Sara MasonOmaha$12K
- Sally CampbellOmaha$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.